Wedbush Remains Bullish on Voyager Therapeutics (VYGR) Following 4Q Financials

March 18, 2016 8:29 AM

Wedbush reiterated an Outperform rating and $36.00 price target on Voyager Therapeutics (NASDAQ: VYGR) following 4Q financial results. Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found